259 related articles for article (PubMed ID: 19523857)
1. Contrast-enhanced transrectal ultrasound (CE-TRUS) with cadence-contrast pulse sequence (CPS) technology for the identification of prostate cancer.
Seitz M; Gratzke C; Schlenker B; Buchner A; Karl A; Roosen A; Singer BB; Bastian PJ; Ergün S; Stief CG; Reich O; Tilki D
Urol Oncol; 2011; 29(3):295-301. PubMed ID: 19523857
[TBL] [Abstract][Full Text] [Related]
2. The value and limitations of contrast-enhanced transrectal ultrasonography for the detection of prostate cancer.
Zhao HX; Xia CX; Yin HX; Guo N; Zhu Q
Eur J Radiol; 2013 Nov; 82(11):e641-7. PubMed ID: 23916578
[TBL] [Abstract][Full Text] [Related]
3. The potential value of power Doppler ultrasound imaging compared with grey-scale ultrasound findings in the diagnosis of local recurrence after radical prostatectomy.
Tamsel S; Killi R; Apaydin E; Hekimgil M; Demirpolat G
Clin Radiol; 2006 Apr; 61(4):325-30; discussion 323-4. PubMed ID: 16546462
[TBL] [Abstract][Full Text] [Related]
4. Transrectal colour Doppler contrast sonography in the diagnosis of local recurrence after radical prostatectomy--comparison with MRI.
Drudi FM; Giovagnorio F; Carbone A; Ricci P; Petta S; Cantisani V; Ferrari FS; Marchetti F; Passariello R
Ultraschall Med; 2006 Apr; 27(2):146-51. PubMed ID: 16602039
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced transrectal ultrasonography for the detection of diffuse prostate cancer.
Gao Y; Liao XH; Lu L; Wang L; Ma Y; Qin HZ; Yan X; Guo P
Clin Radiol; 2016 Mar; 71(3):258-64. PubMed ID: 26738964
[TBL] [Abstract][Full Text] [Related]
6. Prostate Contrast Enhanced Transrectal Ultrasound Evaluation of the Prostate With Whole-Mount Prostatectomy Correlation.
Trabulsi EJ; Calio BP; Kamel SI; Gomella LG; Forsberg F; McCue P; Halpern EJ
Urology; 2019 Nov; 133():187-191. PubMed ID: 31377256
[TBL] [Abstract][Full Text] [Related]
7. PCA3 urinary test versus 1H-MRSI and DCEMR in the detection of prostate cancer foci in patients with biochemical alterations.
Panebianco V; Sciarra A; De Berardinis E; Busetto GM; Lisi D; Buonocore V; Gentile V; Di Silverio F; Passariello R
Anticancer Res; 2011 Apr; 31(4):1399-405. PubMed ID: 21508392
[TBL] [Abstract][Full Text] [Related]
8. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.
Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R
Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of transrectal ultrasound scan of the prostate with sector biopsies for 323 New Zealand men with suspicion of prostate cancer.
Smart R
N Z Med J; 1999 Dec; 112(1101):465-9. PubMed ID: 10678211
[TBL] [Abstract][Full Text] [Related]
10. Comparison of prostate volume measured by transrectal ultrasound and magnetic resonance imaging: is transrectal ultrasound suitable to determine which patients should undergo active surveillance?
Weiss BE; Wein AJ; Malkowicz SB; Guzzo TJ
Urol Oncol; 2013 Nov; 31(8):1436-40. PubMed ID: 22503576
[TBL] [Abstract][Full Text] [Related]
11. Early localization of recurrent prostate cancer after prostatectomy by endorectal coil magnetic resonance imaging.
Linder BJ; Kawashima A; Woodrum DA; Tollefson MK; Karnes J; Davis BJ; Rangel LJ; King BF; Mynderse LA
Can J Urol; 2014 Jun; 21(3):7283-9. PubMed ID: 24978358
[TBL] [Abstract][Full Text] [Related]
12. [Role of prostate fossa ultrasonography in the diagnosis of local recurrence after radical prostatectomy in case of PSA failure].
Roscigno M; Scattoni V; Raber M; Consonni P; Montorsi F; Pasta A; Bertini R; Colombo R; Da Pozzo L; Freschi M; Rigatti P
Arch Ital Urol Androl; 2002 Dec; 74(4):304-8. PubMed ID: 12508759
[TBL] [Abstract][Full Text] [Related]
13. First results of endocavity evaluation of the microvascularization of malignant prostate tumors using contrast enhanced ultrasound (CEUS) including perfusion analysis: first results.
Jung EM; Wiggermann P; Greis C; Eder F; Ehrich J; Jung W; Schreyer AG; Stroszczynski C; Ganzer R
Clin Hemorheol Microcirc; 2012; 52(2-4):167-77. PubMed ID: 22975940
[TBL] [Abstract][Full Text] [Related]
14. [Possibilities of using magnetic resonance imaging-transrectal ultrasound fusion in the diagnosis of recurrent prostate cancer].
Kapustin VV
Vestn Rentgenol Radiol; 2011; (3):53-6. PubMed ID: 22288135
[TBL] [Abstract][Full Text] [Related]
15. Transrectal ultrasound versus magnetic resonance imaging in the estimation of prostate volume as compared with radical prostatectomy specimens.
Lee JS; Chung BH
Urol Int; 2007; 78(4):323-7. PubMed ID: 17495490
[TBL] [Abstract][Full Text] [Related]
16. Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detection.
Perdonà S; Di Lorenzo G; Autorino R; Buonerba C; De Sio M; Setola SV; Fusco R; Ronza FM; Caraglia M; Ferro M; Petrillo A
Urol Oncol; 2013 Aug; 31(6):761-5. PubMed ID: 21906966
[TBL] [Abstract][Full Text] [Related]
17. [The digital rectal exam, prostate-specific antigen and transrectal echography in the diagnosis of prostatic cancer].
Martínez de Hurtado J; Chéchile Toniolo G; Villavicencio Mavrich H
Arch Esp Urol; 1995 Apr; 48(3):247-59. PubMed ID: 7538749
[TBL] [Abstract][Full Text] [Related]
18. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients.
Baco E; Ukimura O; Rud E; Vlatkovic L; Svindland A; Aron M; Palmer S; Matsugasumi T; Marien A; Bernhard JC; Rewcastle JC; Eggesbø HB; Gill IS
Eur Urol; 2015 Apr; 67(4):787-94. PubMed ID: 25240973
[TBL] [Abstract][Full Text] [Related]
20. 11C-choline positron-emission tomography/computed tomography and transrectal ultrasonography for staging localized prostate cancer.
Rinnab L; Blumstein NM; Mottaghy FM; Hautmann RE; Küfer R; Hohl K; Reske SN
BJU Int; 2007 Jun; 99(6):1421-6. PubMed ID: 17355373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
